Nyctea Technologies logo

Nyctea Technologies

Creating new purification and administration of Biopharmaceuticals using electronically activated biomolecule control

8 employees · est. 2020 · Sweden

VS
RedShiftBio logo

RedShiftBio

See Change

31 employees · est. 2005 · United States

RedShiftBio is the older company (2020 vs 2005); RedShiftBio is the larger of the two.

Side-by-Side Comparison

Nyctea Technologies RedShiftBio
Founded
2020 2005 older
Headquarters
Sweden United States
Employees
8 31 larger
Industry
Biotechnology Biotechnology, Design, Enterprise Software
Funding Stage
Convertible Note Series E
Total Funding
$1.55M $65.75M
Funding Rounds
3 7
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biopharmaceuticals, Protein Production, Patent-pending Invention, Functionalized Polymer Surfaces, Biomolecule Purification, Biomolecule Administration, Electronically Activated Control, Bioprocessing, Biomolecular Capture, Biomolecular Release, Digital Biopharmaceutical Manufacturing, High Specificity, High Capacity Capture, Simpler Biopharmaceutical Production, Effective Biomolecule Control Biopharmaceuticals, Protein Analysis, Bioprocess Analytics, Spectroscopy, Quantum Cascade Lasers, Molecular Structure, Instrumentation, Biomolecule Stability, Biopharmaceutical Manufacturing, Microfluidic Modulation Spectroscopy, Technology, Venture Capital, Innovation
Website
nycteatechnologies.com redshiftbio.com
Nyctea Technologies logo

About Nyctea Technologies

### Nyctea Technologies Analysis Nyctea Technologies is a biotechnology startup founded in 2020 and headquartered in Sweden. The company specializes in the creation of new purification and administration methods for biopharmaceuticals using electronically activated biomolecule control. With its pa...

RedShiftBio logo

About RedShiftBio

RedShiftBio, with the slogan "See Change," is revolutionizing protein structure and concentration analysis. The company's proprietary life sciences platform utilizes Microfluidic Modulation Spectroscopy (MMS) and high-powered quantum cascade lasers to deliver precise measurements of molecular struct...

We will tell you when either one moves

BounceWatch watches Nyctea Technologies and RedShiftBio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Nyctea Technologies and RedShiftBio — by email.

Frequently Asked Questions

Nyctea Technologies — Creating new purification and administration of Biopharmaceuticals using electronically activated biomolecule control. RedShiftBio — See Change. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Nyctea Technologies has raised $1.55M while RedShiftBio has raised $65.75M.
Nyctea Technologies and RedShiftBio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Nyctea Technologies with someone else

Start typing a company name or domain.

Related Comparisons

Compiled from the BounceWatch company index. We last looked at Nyctea Technologies on 11 Sep 2024, and RedShiftBio on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy